Neuraptive Therapeutics, Inc. is a Philadelphia-based company dedicated to developing innovative therapeutics and medical products for physicians and patients affected by peripheral nerve injuries. With a focus on improving the speed and outcomes of peripheral nerve injuries, Neuraptive has in-licensed technology from the University of Texas at Austin, including a novel fusion system for repairing severed peripheral nerves, a specialized drug delivery device for topical administration, and nerve-specific microsurgical instruments to address current limitations in the field of nerve repair.
With their revolutionary surgical treatment kit, NTX-001, Neuraptive aims to revolutionize nerve repair by leveraging the 505(b)(2) development pathway and utilizing previously approved pharmaceutical ingredients presented in sterile solutions. With a significant market opportunity in the US and globally, Neuraptive's products have the potential to make a substantial impact on the lives of millions of patients undergoing nerve repair procedures.
Generated from the website